Labeler
Apotex Corp. NDC Codes
Apotex Corp. lists 344 finished drug products in the FDA NDC Directory under NDC labeler code 60505.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Dexamethasone, Lisdexamfetamine Dimesylate, Dasatinib, Brivaracetam, Ceftaroline Fosamil, Pomalidomide, Nuvigil, Eslicarbazepine Acetate, Tofacitinib, Sitagliptin, Nilotinib, Oxcarbazepine, dabigatran etexilate, Sitagliptin and Metformin Hydrochloride, Dapagliflozin
- Active ingredients
- Dexamethasone, Lisdexamfetamine dimesylate, Dasatinib, Sitagliptin phosphate, Brivaracetam, Ceftaroline fosamil, Pomalidomide, Armodafinil, Eslicarbazepine acetate, Nilotinib, Oxcarbazepine, Dabigatran etexilate mesylate
- NDC labeler codes
- 60505
- Strengths (from the 100 most recently listed products)
- Sitagliptin phosphate 50 mg/1; Ceftaroline fosamil 400 mg/20mL; Ceftaroline fosamil 600 mg/20mL; Eribulin mesylate .5 mg/mL; Trabectedin .05 mg/mL; Hydrocortisone sodium succinate 100 mg/2mL; Macitentan 10 mg/1; Tofacitinib citrate 11 mg/1; Tofacitinib 5 mg/1; Tofacitinib 10 mg/1; Sitagliptin phosphate 25 mg/1; Metformin hydrochloride 1000 mg/1; Sitagliptin phosphate 100 mg/1; Metformin hydrochloride 500 mg/1; Dapagliflozin 5 mg/1; Dapagliflozin 10 mg/1; Nintedanib esylate 150 mg/1; Nintedanib esylate 100 mg/1; Pomalidomide 1 mg/1; Pomalidomide 2 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Kit, Injection, Powder, Lyophilized, For solution, Injection, Injection, Solution, Tablet, Extended release, Injection, Powder, For solution, Injection, Solution, Concentrate, Tablet, Film coated, Extended release, Solution/ drops, Spray, Metered
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Ophthalmic, Nasal
- Drug classes (FDA established)
- Kinase Inhibitor, Corticosteroid, Central Nervous System Stimulant, Cephalosporin Antibacterial, Dipeptidyl Peptidase 4 Inhibitor, Thalidomide Analog, Janus Kinase Inhibitor, P2Y12 Platelet Inhibitor, Anti-epileptic Agent, Direct Thrombin Inhibitor, Alkylating Drug, Biguanide, Sodium-Glucose Cotransporter 2 Inhibitor, Sympathomimetic-like Agent, Serotonin-4 Receptor Agonist, Microtubule Inhibitor, Copper Absorption Inhibitor, Platinum-based Drug, Pyridone, Endothelin Receptor Antagonist, Macrolide Antibacterial, Purine Antimetabolite, Serotonin-3 Receptor Antagonist, Factor Xa Inhibitor, Pharmacologic Cardiac Stress Test Agent, Tetracycline-class Drug, Nonsteroidal Anti-inflammatory Drug, Nucleoside Metabolic Inhibitor, Melatonin Receptor Agonist, Parathyroid Hormone Analog
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 125 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Eslicarbazepine Acetate | Eslicarbazepine acetate 200 mg/1 | TabletOral | 60505-4658 | 60505-4658-0360505-4658-09 | — |
| Eslicarbazepine Acetate | Eslicarbazepine acetate 600 mg/1 | TabletOral | 60505-4660 | 60505-4660-0660505-4660-09 | — |
| Eslicarbazepine Acetate | Eslicarbazepine acetate 800 mg/1 | TabletOral | 60505-4661 | 60505-4661-0360505-4661-09 | — |
| Rivaroxaban | Rivaroxaban 2.5 mg/1 | Tablet, Film coatedOral | 60505-6256 | 60505-6256-0560505-6256-06 | — |
| Ticagrelor | Ticagrelor 90 mg/1 | TabletOral | 60505-4452 | 60505-4452-06 | — |
| Regadenoson | Regadenoson .08 mg/mL | Injection, SolutionIntravenous | 60505-6288 | 60505-6288-00 | — |
| eribulin mesylate | Eribulin mesylate .5 mg/mL | InjectionIntravenous | 60505-6435 | 60505-6435-00 | — |
| Prasugrel | Prasugrel hydrochloride 10 mg/1 | Tablet, Film coatedOral | 60505-4856 | 60505-4856-03 | — |
| Zinc Sulfatezinc sulfate injection | Zinc sulfate, Unspecified form 1 mg/mL | InjectionIntravenous | 60505-6261 | 60505-6261-05 | — |
| Doxycycline | Doxycycline 40 mg/1 | CapsuleOral | 60505-4775 | 60505-4775-03 | — |
| CISplatin | Cisplatin 1 mg/mL | Injection, SolutionIntravenous | 60505-6279 | 60505-6279-00 | — |
| Dasatinib | Dasatinib 50 mg/1 | Tablet, Film coatedOral | 60505-3629 | 60505-3629-06 | — |
| Dasatinib | Dasatinib 20 mg/1 | Tablet, Film coatedOral | 60505-3628 | 60505-3628-06 | — |
| Dasatinib | Dasatinib 70 mg/1 | Tablet, Film coatedOral | 60505-3630 | 60505-3630-06 | — |
| Dasatinib | Dasatinib 100 mg/1 | Tablet, Film coatedOral | 60505-3631 | 60505-3631-03 | — |
| Dasatinib | Dasatinib 80 mg/1 | Tablet, Film coatedOral | 60505-3816 | 60505-3816-03 | — |
| Dasatinib | Dasatinib 140 mg/1 | Tablet, Film coatedOral | 60505-3817 | 60505-3817-03 | — |
| Oxcarbazepine | Oxcarbazepine 300 mg/1 | Tablet, Extended releaseOral | 60505-4129 | 60505-4129-0560505-4129-07 | — |
| Oxcarbazepine | Oxcarbazepine 150 mg/1 | Tablet, Extended releaseOral | 60505-4128 | 60505-4128-0560505-4128-07 | — |
| Oxcarbazepine | Oxcarbazepine 600 mg/1 | Tablet, Extended releaseOral | 60505-4130 | 60505-4130-0560505-4130-07 | — |
| Zinc Sulfatezinc sulfate injection | Zinc sulfate, Unspecified form 5 mg/mL | InjectionIntravenous | 60505-6260 | 60505-6260-05 | — |
| Bromfenac Ophthalmic Solution, 0.07%bromfenac sodium | Bromfenac sodium .7 mg/mL | Solution/ dropsOphthalmic | 60505-1006 | 60505-1006-0160505-1006-02 | — |
| Cetrorelix acetatecetrorelix acetate for injection | — | KitSubcutaneous | 60505-6270 | 60505-6270-01 | — |
| eribulin mesylate | Eribulin mesylate .5 mg/mL | InjectionIntravenous | 60505-6289 | 60505-6289-00 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 60505-6287 | 60505-6287-0260505-6287-04 | — |
| Pirfenidone | Pirfenidone 801 mg/1 | TabletOral | 60505-4682 | 60505-4682-09 | — |
| Pirfenidone | Pirfenidone 267 mg/1 | TabletOral | 60505-4681 | 60505-4681-0760505-4681-09 | — |
| Cefazolin | Cefazolin sodium 3 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 60505-6266 | 60505-6266-05 | — |
| dabigatran etexilate | Dabigatran etexilate mesylate 110 mg/1 | CapsuleOral | 60505-4349 | 60505-4349-06 | — |
| dabigatran etexilate | Dabigatran etexilate mesylate 75 mg/1 | CapsuleOral | 60505-4347 | 60505-4347-06 | — |
| dabigatran etexilate | Dabigatran etexilate mesylate 150 mg/1 | CapsuleOral | 60505-4348 | 60505-4348-06 | — |
| Triamcinolone acetonide | Triamcinolone acetonide 55 ug/1 | Spray, MeteredNasal | 60505-6275 | 60505-6275-07 | — |
| Azacitidine | Azacitidine 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 60505-6271 | 60505-6271-01 | — |
| Varenicline | — | KitOral | 60505-3615 | 60505-3615-04 | — |
| Tasimelteon | Tasimelteon 20 mg/1 | CapsuleOral | 60505-4665 | 60505-4665-0360505-4665-09 | — |
| Dexamethasone | Dexamethasone .75 mg/1 | TabletOral | 60505-6250 | 60505-6250-01 | — |
| Dexamethasone | Dexamethasone .5 mg/1 | TabletOral | 60505-6249 | 60505-6249-01 | — |
| Dexamethasone | Dexamethasone 1.5 mg/1 | TabletOral | 60505-6252 | 60505-6252-01 | — |
| Dexamethasone | Dexamethasone 6 mg/1 | TabletOral | 60505-6255 | 60505-6255-01 | — |
| Teriparatide | Teriparatide 250 ug/mL | Injection, SolutionSubcutaneous | 60505-6188 | 60505-6188-00 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 30 mg/1 | CapsuleOral | 60505-4741 | 60505-4741-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 10 mg/1 | CapsuleOral | 60505-4739 | 60505-4739-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 20 mg/1 | CapsuleOral | 60505-4740 | 60505-4740-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 40 mg/1 | CapsuleOral | 60505-4742 | 60505-4742-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 50 mg/1 | CapsuleOral | 60505-4743 | 60505-4743-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 60 mg/1 | CapsuleOral | 60505-4744 | 60505-4744-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 70 mg/1 | CapsuleOral | 60505-4745 | 60505-4745-01 | — |
| Dexamethasone | Dexamethasone 2 mg/1 | TabletOral | 60505-6253 | 60505-6253-01 | — |
| Dexamethasone | Dexamethasone 1 mg/1 | TabletOral | 60505-6251 | 60505-6251-01 | — |
| Dexamethasone | Dexamethasone 4 mg/1 | TabletOral | 60505-6254 | 60505-6254-01 | — |
Apotex Corp.: common questions
- What is Apotex Corp.'s NDC labeler code?
- 60505. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Apotex Corp.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.